| Primary |
| Colon Cancer |
20.3% |
| Colorectal Cancer |
17.2% |
| Rectal Cancer |
7.5% |
| Colorectal Cancer Metastatic |
6.9% |
| Premedication |
6.8% |
| Gastric Cancer |
5.7% |
| Colon Cancer Metastatic |
4.8% |
| Pancreatic Carcinoma |
4.0% |
| Metastatic Gastric Cancer |
3.1% |
| Hypertension |
2.8% |
| Large Intestine Carcinoma |
2.7% |
| Glioblastoma |
2.4% |
| Pyrexia |
2.3% |
| Constipation |
2.2% |
| Prophylaxis |
2.2% |
| Nausea |
2.1% |
| Metastases To Liver |
1.9% |
| Pancreatic Carcinoma Metastatic |
1.9% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Small Cell Lung Cancer Stage Unspecified |
1.6% |
|
| Death |
31.6% |
| Disease Progression |
10.5% |
| Diarrhoea |
9.3% |
| Vomiting |
7.8% |
| Thrombocytopenia |
7.6% |
| Neuropathy Peripheral |
4.2% |
| Neutropenia |
4.0% |
| Pyrexia |
3.3% |
| Rash |
2.9% |
| Pneumonia |
2.2% |
| Weight Decreased |
2.2% |
| Pancreatic Carcinoma |
2.0% |
| Hepatic Failure |
1.8% |
| Sepsis |
1.8% |
| Muscle Spasms |
1.6% |
| Interstitial Lung Disease |
1.5% |
| Nausea |
1.5% |
| Neoplasm Malignant |
1.5% |
| Urinary Tract Infection |
1.5% |
| White Blood Cell Count Decreased |
1.5% |
|
| Secondary |
| Colorectal Cancer |
19.0% |
| Colon Cancer |
18.6% |
| Colon Cancer Metastatic |
9.9% |
| Drug Use For Unknown Indication |
7.4% |
| Colorectal Cancer Metastatic |
6.8% |
| Premedication |
5.1% |
| Colon Cancer Stage Iv |
4.1% |
| Nausea |
4.0% |
| Rectal Cancer |
3.6% |
| Cancer Pain |
3.2% |
| Adenocarcinoma |
2.9% |
| Prophylaxis |
2.2% |
| Large Intestine Carcinoma |
2.0% |
| Metastases To Liver |
1.9% |
| Hypertension |
1.7% |
| Hepatic Neoplasm Malignant |
1.7% |
| Vomiting |
1.6% |
| Diarrhoea |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.4% |
| Small Cell Lung Cancer Stage Unspecified |
1.4% |
|
| Vomiting |
10.2% |
| Diarrhoea |
8.7% |
| Pyrexia |
8.1% |
| Septic Shock |
7.5% |
| Thrombocytopenia |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Pulmonary Embolism |
5.7% |
| Weight Decreased |
5.7% |
| Death |
4.5% |
| Neutropenia |
4.5% |
| Disease Progression |
4.2% |
| Small Intestinal Perforation |
4.2% |
| Neuropathy Peripheral |
3.9% |
| Erythrosis |
3.3% |
| Stomatitis |
3.0% |
| Malaise |
2.7% |
| Paraesthesia |
2.7% |
| Peritonitis |
2.7% |
| Rash |
2.4% |
| Renal Failure |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.7% |
| Premedication |
14.8% |
| Colon Cancer |
12.2% |
| Colorectal Cancer |
9.3% |
| Rectal Cancer |
6.1% |
| Colon Cancer Metastatic |
5.6% |
| Metastases To Bone |
4.5% |
| Colorectal Cancer Metastatic |
4.3% |
| Cancer Pain |
2.8% |
| Large Intestine Carcinoma |
2.8% |
| Prophylaxis |
2.8% |
| Pain |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.3% |
| Breast Cancer |
1.8% |
| Nausea |
1.6% |
| Constipation |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Prophylaxis Against Diarrhoea |
1.1% |
| Rectal Cancer Metastatic |
1.1% |
| Adenocarcinoma |
1.0% |
|
| Death |
11.9% |
| Rash |
11.1% |
| Infusion Related Reaction |
7.1% |
| Pyrexia |
7.1% |
| Vomiting |
7.1% |
| Interstitial Lung Disease |
4.8% |
| Skin Ulcer |
4.8% |
| Drug Ineffective |
4.0% |
| Malignant Neoplasm Progression |
4.0% |
| Road Traffic Accident |
4.0% |
| Septic Shock |
4.0% |
| Tooth Extraction |
4.0% |
| Weight Decreased |
4.0% |
| Dermatitis Acneiform |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Febrile Neutropenia |
3.2% |
| Hypertension |
3.2% |
| Metastases To Liver |
3.2% |
| Osteonecrosis |
3.2% |
| Tooth Loss |
3.2% |
|
| Interacting |
| Glioblastoma |
46.2% |
| Alveolar Soft Part Sarcoma |
23.1% |
| Drug Use For Unknown Indication |
23.1% |
| Antifungal Prophylaxis |
7.7% |
|
| Skin Necrosis |
50.0% |
| Hepatic Function Abnormal |
25.0% |
| Mucosal Inflammation |
25.0% |
|
